Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Serum and urine levels following parenteral administration of sodium colistimethate to normal individuals.

× No keyword cloud information.

7 in total

Review 1. Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references.

Authors: L A Pagliaro; L Z Benet
Journal: J Pharmacokinet Biopharm Date: 1975-10

2. Colistin methanesulfonate is an inactive prodrug of colistin against Pseudomonas aeruginosa.

Authors: Phillip J Bergen; Jian Li; Craig R Rayner; Roger L Nation
Journal: Antimicrob Agents Chemother Date: 2006-06 Impact factor: 5.191

Review 3. Polymyxins revisited.

Authors: David Landman; Claudiu Georgescu; Don Antonio Martin; John Quale
Journal: Clin Microbiol Rev Date: 2008-07 Impact factor: 26.132

4. Intravenous colistin sulphomethate in acute respiratory exacerbations in adult patients with cystic fibrosis.

Authors: S P Conway; M N Pond; A Watson; C Etherington; H L Robey; M H Goldman
Journal: Thorax Date: 1997-11 Impact factor: 9.139

5. Urinary Concentrations of Colistimethate and Formed Colistin after Intravenous Administration in Patients with Multidrug-Resistant Gram-Negative Bacterial Infections.

Authors: Sonia Luque; Carol Escaño; Luisa Sorli; Jian Li; Nuria Campillo; Juan Pablo Horcajada; Esther Salas; Santiago Grau
Journal: Antimicrob Agents Chemother Date: 2017-07-25 Impact factor: 5.191

6. Synergistic activity of colistin and ceftazidime against multiantibiotic-resistant Pseudomonas aeruginosa in an in vitro pharmacodynamic model.

Authors: Brent W Gunderson; Khalid H Ibrahim; Laurie B Hovde; Timothy L Fromm; Michael D Reed; John C Rotschafer
Journal: Antimicrob Agents Chemother Date: 2003-03 Impact factor: 5.191

7. Colistin: recent data on pharmacodynamics properties and clinical efficacy in critically ill patients.

Authors: Argyris S Michalopoulos; Matthew E Falagas
Journal: Ann Intensive Care Date: 2011-08-02 Impact factor: 6.925

7 in total